Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.

Philip James JohnsonHamish InnesDavid M HughesAnton KalyuzhnyyTakashi KumadaHidenori Toyoda

Published in: British journal of cancer (2022)

The results from this 'real-world' cohort demonstrate that risk stratification is a realistic prospect and that identification of a subgroup of chronic liver disease patients who have a very low risk of HCC is feasible.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
public health
prognostic factors
randomized controlled trial
clinical trial
patient reported outcomes
study protocol
patient reported